Biguanid

Carbamimidamidomethanimidamide

HCID 176517607

Grundinformationen

CAS
56-03-1
Standard-SMILES
N=C(N)NC(=N)N
InChIKey
XNCOSPRUTUOJCJ-UHFFFAOYSA-N
Summenformel
C2H7N5
Durchschnittliche Molmasse
101,11 g/mol
Monoisotopische Masse
101,07014522

Überblick

Biguanide has been investigated for the treatment of Diabetes Mellitus.

Namen und Bezeichner

Bevorzugter Name
Carbamimidamidomethanimidamide
IUPAC
1-carbamimidoylguanidine
Lokaler Name
Biguanid
Englischer Name
Biguanide
Summenformel
C2H7N5
Molmasse
101.11

Namen und Synonyme

carbamimidamidomethanimidamideBiguanidesSCHEMBL8039SCHEMBL53106orb1986383SCHEMBL2450599SCHEMBL3431407CHEMBL4297654EBC-26039[(diaminomethylidene)amino]methanimidamideNS00000796EN300-126001
Weitere Namen anzeigen
IMidodicarboniMidicdiaMideAI352571AI3 52571diguanideBiguanideAI3-52571guanylguanidineamidinoguanidine2-Amidinoguanidine2-carbamimidoylguanidine
G89733T30450Q142880

Datenbank-Bezeichner

CAS
56-03-1
PubChem CID
176517607
DTXSID
DTXSID7074664
ChEMBL
CHEMBL4297654
UNII
FB4Q52I9K2
Nikkaji
J4.565I

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-1,6
Polarare Oberfläche (TPSA)
112 Ų
H-Brücken-Donoren
5
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
2
Schwere Atome
7

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15

Physikochemische Eigenschaften

Schmelzpunkt
130 ° · 130°
Siedepunkt
189.3 · 189.3±23.0 °C(Predicted)
Dichte
1.8 · 1.80±0.1 g/cm3(Predicted)
Brechungsindex
1.71 · 1.7100 (estimate)
storage temp.
-20 °C · Storage temp. -20°C
pka
11.52 · 11.52, 2.93(at 25℃)

Chemie und Industrie

Anwendungen · 2 Einträge

BeschreibungFrench physician Jean Sterne published the first clinical trial in 1957 suggesting metformin as a treatment for diabetes. The United Kingdom introduced this drug in 1958 followed by Canada in 1972, and the United States in 1995. As of 2010, metformin was one of only two oral antidiabetics in the World Health Organization model list of essential medicines, the other being glibenclamide. Metformin is believed to enjoy the popularity of being the most widely prescribed antidiabetic drug in the world. It has been estimated that the United States alone has filled nearly a million prescriptions in 2010 for its generic formulations. Biguanides are not hypoglycemic agents; rather they promote euglycemia (antihyperglycemic). Biguanides are used both as monotherapy and in combination with other oral hypoglycemic agents to control hyperglycemia. Although very safe in most instances, the major toxicity from acute or chronic use of biguanides has been reported to be lactic acidosis. In fact, the high rate of severe lactic acidosis was the only major cause of withdrawal of phenformin from the US market in 1976.

VerwendenBiguanides are used as an oral drug for the management of mild to moderately severe noninsulin-dependent diabetes mellitus, or NIDDM, (Type II) in obese or overweight patients who are usually above 40 years of age. It is important that for the administration of this drug the disease should have adult onset. Polymeric biguanides were originally developed as a presurgery antimicrobial scrub and in 1977, it was introduced in the market for treating pools and spas as a disinfectant under the trade name Baquacil. The US Environmental Protection Agency approved this agent as the only nonhalogen sanitizer of pools and spas. Biguanide itself is combined with algaecides and hydrogen peroxide for periodic oxidation of pools and spas. Biguanides are incompatible with chlorine, ozone, detergents, and ionizers, but are compatible with water ion balancing chemicals. Biguanide in the form of polyaminopropyl biguanide serves as a disinfectant, and preservative for skin disinfection, contact lens cleaning solutions, and deodorant body sprays. Biguanides reduce the surface tension of water, which gives it a smoother feeling. They are stable in sunlight and temperature. At recommended concentrations when used in pools and spas, biguanides do not irritate the skin or eyes and do not corrode the pool equipment.

Anbieter23 Anbieter

上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
Hangzhou Sage Chemical Co., Ltd.+86057186818502 13588463833 · [email protected]
SelectLab Chemicals GmbH+49-(0)2383-919350 · [email protected]
湖北成海化工有限公司027-59220433 18327245847 · [email protected]
上海皓鸿生物医药科技有限公司400-8210725 4008210725 · [email protected]

Zugehörige Reaktionen

11

Notizen zur Verbindung

Wird geladen…